BMW's 8,000-Job Restructuring Signals a Hard Pivot as China Slump Bites
Published on 08/04/2026 at 02:51 | Redaktion boerse-global.de
Investors gave BMW's most aggressive cost-cutting program in years a cautious thumbs-up on Monday, sending the automaker's shares higher even as the company confirmed it will shed roughly 8,000 positions by the end of 2027. The muted rally — a gain of just over 1% to around €60 — suggests the market views the overhaul as a necessary correction rather than a red flag, a notable shift in sentiment for a stock that has shed more than a third of its value this year.
The restructuring, which targets administrative functions, product planning and development rather than factory floors, will be executed primarily through natural attrition and a voluntary severance program in Germany. From October, around 40,000 of the company's 85,000 domestic employees will receive buyout offers. BMW, which employs roughly 154,000 people worldwide with more than half based in Germany, is aiming for annual savings of €1 billion from 2028 under the banner of "more speed, more efficiency."
Speaking of efficiency and restructuring — when companies overhaul their operations, they often overlook a critical piece of the puzzle: workplace safety documentation. A free Risk Assessment Toolkit with 41 ready-to-use templates and checklists can help you manage workplace risks effectively while your business goes through change. Download the free Risk Assessment Toolkit
A Balance Sheet Under Pressure
The urgency behind the job cuts becomes clear when examining the first-half numbers. Net profit fell 28.5% to €2.872 billion, while operating profit tumbled 37.4% to €3.635 billion and revenue slipped 8% to €62.266 billion. The second quarter was particularly brutal for the core automotive division, where EBIT collapsed 60% to just €629 million. Group pre-tax profit for the quarter dropped 35.1% to €1.697 billion.
China remains the primary drag. Deliveries there fell 20.4% in the first quarter before accelerating to a 30.2% decline in the second. Growth elsewhere — 7.6% in Europe and 11.9% in the US — could not offset the shortfall. BMW attributes the weakness to intensifying competition, regulatory headwinds, the Middle East conflict and, crucially, a gap in its electric vehicle lineup that has left it exposed to cheaper rivals.
The company's early bet on carbon-fiber construction for its i-series models proved costly. The i3 sold just 250,000 units over nine years, while the iX managed 130,000 in four. Development of the i3 and i8 reportedly cost between €2 billion and €3 billion, plus a €100 million investment in a carbon-fiber joint venture with SGL back in 2011. Production of the i5 has since been paused. With battery-electric vehicles accounting for 18% of sales last year — 442,000 units — BMW has yet to deliver the cost-efficient EV platform needed to compete on price. The company has, however, produced 50,000 units of its new iX3 electric model, with around 100,000 orders expected, and plans to launch more than 40 new models by the end of 2027.
Analyst Divergence and a Stock in the Doldrums
Wall Street's reaction to the numbers has been split. Goldman Sachs trimmed its price target from €84 to €82 but maintained a "Buy" rating, citing higher provisions for severance costs. Analyst Christian Frenes has shifted focus to China profitability and the pace of restructuring. Deutsche Bank remains more bullish, with Tim Rokossa reaffirming a "Buy" and a €90 target after an investor event, while acknowledging ongoing discussions about market trends and potential impairment risks in China. Jefferies' Philippe Houchois is more cautious, keeping a "Hold" rating and €70 target, noting the figures came as little surprise following the company's mid-June guidance cut. He points to the capital markets day scheduled for late September as the key moment for management to address profitability and reputation. Across the street, price targets range from €65 to €90, with a predominantly positive tilt.
The shares, trading around €60, sit roughly 4% below their 50-day average of €63.02 but about 7% above the 52-week low of €56.40 hit in July. The stock has lost approximately 35% since the start of the year — a decline that reflects deep skepticism about the China franchise, yet also explains why even modest positive signals are being welcomed.
Restructuring brings risk — and not just financial. When companies streamline operations, workplace safety can slip through the cracks. Over 37,000 UK businesses trust this free Health & Safety Toolkit to stay compliant with regulations like the Health & Safety at Work Act and keep employees protected through periods of change. Get the free Health & Safety Toolkit
Capital Returns and Operational Resilience
Despite the earnings squeeze, BMW is pressing ahead with its 2025/2027 share buyback program. Between July 27 and August 2, the company repurchased 383,262 common shares at volume-weighted average prices ranging from €57.59 to €60.64 via Xetra — a signal that management intends to keep returning capital to shareholders even amid the austerity drive.
The company has also demonstrated operational agility on other fronts. When low water levels forced the shutdown of a nuclear power plant in Hungary, BMW cut energy consumption at its Debrecen factory by 15%, aided by a 50-hectare solar array capable of generating up to 50 megawatts. While Ford and Dacia temporarily halted production in Romania as a result of the same issue, BMW kept Debrecen running without interruption — a small but telling example of how the company is managing near-term operational risks better than the structural challenges it faces in China.
The broader picture, however, remains demanding. A solid order pipeline in the US and Europe is offset by persistent weakness in China, and the full benefits of the cost program will not materialize until 2028 at the earliest. For now, BMW is betting that a leaner administrative structure, a refreshed model lineup and continued capital returns will be enough to steady the ship through what remains a turbulent period for the industry.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
